ARTICLE | Company News

Ariad other research news

April 24, 2000 7:00 AM UTC

ARIA collaborators published in Blood the use of ARIA’s AP1903 small molecule dimerizing compound to promote the growth of red blood cells from progenitor cells that had been isolated from human umbilical cord blood and modified using ARIA’s Argent gene expression system. They showed that CD34+ cells transfected with the thrombopoietin receptor (mpl) expanded 14-186 fold in the presence of AP1903 compared to cells cultured without AP1903. ...